DEVELOPMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL APPLICATIONS

Recombinant human serum albumin (OsrHSA) has emerged as an important innovation in the field of biopharmaceuticals, offering promising advancements throughout various clinical and industrial programs. With its structural similarity to naturally derived human serum albumin, OsrHSA offers a safer, far more trustworthy alternative for therapeutic use,